GLENMARK

1,984 INR
9
0.46%
Last update Dec 15, 3:29 PM IST
Main market
Day range
1,951
1,990.90002
Previous close
1,975
Open
1,966.099976
Access this stock data via API
Subscribe
Glenmark Pharmaceuticals Ltd.
1,984.00
9
0.46%

Financials

Income statement

Fiscal date 2025 2024 2023 2022
Total reported revenue 131.5B 116.4B 114.3B 121.7B
Cost of revenue 47.6B 48.8B 45.9B 47.8B
Gross profit 83.9B 67.6B 68.5B 74.0B
Operating expense
Research & development
Selling general and admin 16.0B 13.6B 14.3B 13.0B
Other operating expenses 14.1B 13.1B 11.6B 12.6B
Operating income 18.7B 6.3B 10.8B 18.4B
Non operating interest income
Income 439.4M 61.8M 70M 94.4M
Expense 2.1B 5.2B 3.5B 3.0B
Other income expense
Pretax income 14.0B 365.0M 2.4B 14.4B
Tax provision 3.5B 18.7B 3.3B 4.5B
Net income 10.5B -14.3B 3.8B 9.9B
Basic EPS 37.1 -53.2 10.5 33.4
Diluted EPS 37.1 -53.2 10.5 33.4
Basic average shares 282.2M 282.2M 282.2M 282.2M
Diluted average shares 282.2M 282.2M 282.2M 282.2M
EBITDA 24.7B 21.0B 19.7B 24.9B
Net income from continuing op. 14.0B 5.7B 8.7B 14.4B
Minority interests -450K -681.5M -801.6M -519.4M
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 32 minutes

12:58
00:00
09:15
15:30
23:59

Trading Hours (Sunday - Thursday):

Main market
09:15 - 15:30
All times are displayed in the Asia/Kolkata timezone (IST, UTC+05:30).